![]() |
|
|
MS Kleven, CR Schuster and LS Seiden
Department of Pharmacological and Physiological Sciences, University of Chicago, Illinois.
Fenfluramine is an anorectic agent in clinical use that is believed to act by enhancing 5-hydroxytryptamine (5-HT) neurotransmission. Tolerance to the anorectic properties of fenfluramine develops rapidly and long-lasting depletions of brain 5-HT have been reported to occur after repeated administration. It is possible that tolerance to fenfluramine may be related to the 5-HT depletions. Rats (n = 96), previously allowed to drink sweetened condensed milk during daily 15- min sessions, were treated with fenfluramine (6.25 mg/kg/12 hr x 4 days) or saline. Two or 8 weeks later rats were administered fenfluramine acutely (0, 1.25, 6.25 or 12.5 mg/kg; n = 6/group), tested for milk intake and sacrificed 2 hr later. Brains were removed and regions assayed for dopamine, 5-HT and metabolites. Acute administration of fenfluramine produced a dose-dependent decrease in milk intake and 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) levels in cortex, hypothalamus and hippocampus. Tolerance to the effects of acute fenfluramine on milk intake was observed in rats at 2 weeks (ED50 = 3.24 vs. 6.37 mg/kg; saline vs. fenfluramine pretreatment, respectively) and, to a lesser extent, at 8 weeks (ED50 = 2.99 vs. 4.04 mg/kg; saline vs. fenfluramine pretreatment) after the 4-day regimen of fenfluramine. Levels of 5-HT and 5-HIAA in somatosensory cortex, hypothalamus, striatum and hippocampus were depleted significantly 2 weeks after the last daily fenfluramine injection. The acute 5-HT depleting effect of fenfluramine was markedly attenuated in these regions 2 weeks after the 4-day regimen of fenfluramine.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
M. H. Baumann, M. A. Ayestas, and R. B. Rothman Functional Consequences of Central Serotonin Depletion Produced by Repeated Fenfluramine Administration in Rats J. Neurosci., November 1, 1998; 18(21): 9069 - 9077. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Clausing, G. D. Newport, and J. F. Bowyer Fenfluramine and Norfenfluramine Levels in Brain Microdialysate, Brain Tissue and Plasma of Rats Administered Doses of d-Fenfluramine Known to Deplete 5-Hydroxytryptamine Levels in Brain J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 618 - 624. [Abstract] [Full Text] |
||||
![]() |
U. D. Mccann, J. Yuan, G. Hatzidimitriou, and G. A. Ricaurte J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1487 - 1498. [Abstract] |
||||